Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Despite tremendous efforts in the search for safe, efficacious and non-addictive opioids for pain treatment, morphine remains the most valuable painkiller in contemporary medicine. Opioids exert their pharmacological actions through three opioid-receptor classes, mu, delta and kappa, whose genes have been cloned. Genetic approaches are now available to delineate the contribution of each receptor in opioid function in vivo. Here we disrupt the mu-opioid-receptor gene in mice by homologous recombination and find that there are no overt behavioural abnormalities or major compensatory changes within the opioid system in these animals. Investigation of the behavioural effects of morphine reveals that a lack of mu receptors abolishes the analgesic effect of morphine, as well as place-preference activity and physical dependence. We observed no behavioural responses related to delta- or kappa-receptor activation with morphine, although these receptors are present and bind opioid ligands. We conclude that the mu-opioid-receptor gene product is the molecular target of morphine in vivo and that it is a mandatory component of the opioid system for morphine action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, in animal models, dopamine D1 receptor knockout rats will not self-administer cocaine37 and μ opioid receptor knockout mice will not show the rewarding effects of opioids.153”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [153]
In the citing paper
“Mice that lack the MOR gene do not develop place preferences or withdrawal symptoms in response to morphine (Matthes et al 1996).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Matthes et al 1996
Citations
Cites
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationNeutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
Roques, B. P., Noble, F., Daugé, V, Fournié-Zaluski, M. C., & Beaumont, A. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00449-1 · Cited by 756
Self-citationLufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationChiara, G. D., & Alan North, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90062-b · Cited by 543
Terwilliger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M., & Nestler, E. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91111-d · Cited by 535
A brief history of opiates, opioid peptides, and opioid receptors.
Brownstein, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5391 · Cited by 491
Multiple opioid receptors: ligand selectivity profiles and binding site signatures.
Goldstein, A., & Naidu, A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09190-4 · Cited by 445
Kieffer, B. L. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02071128 · Cited by 389
Self-citationReduction of Morphine Abstinence in Mice with a Mutation in the Gene Encoding CREB
Maldonado, R., Blendy, J. A., Tzavara, E., Gass, P., Roques, B. P., Hanoune, J., & Schütz, G. (1996) · Science · doi:10.1126/science.273.5275.657 · Cited by 292
Self-citationThe mouse Pgk-1 gene promoter contains an upstream activator sequence
McBurney, M. W., Sutherland, L. C., Adra, C. N., Leclair, B., Rudnicki, M. A., & Jardine, K. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5755 · Cited by 193
Research works printed but not linked: 9
- Goldstein, A. & Naidu, A. Mol. Pharmacol. 36, 265–272 (1989).
- Pasternak, G. W. Clin. Pharmacol. 16, 1–18 (1993).
- Cowan, A. in Handbook of Experimental Pharmacology Opioids II (ed. Herz, A.) Vol. 104, 393–414 (Springer, Berlin, 1993).
- Roques, B. P., Noble, F., Daugé, V., Fournié-Zaluski, M.-C. & Beaumont, A. Pharmacol. Rev. 45, 87–146 (1993).
- Baamonde, A., Daugé, V., Gacel, C. & Roques, B. P. J. Pharmacol. Exp. Ther. 257, 767–773 (1991).
- Koob, G. F. Trends Biochem. Sci. 13, 177–184 (1992).
- Wei, E. T. J. Pharmacol. Exp. Ther. 216, 12–18 (1981).
- Cowan, A., Zhu, X. Z., Mosberg, H. I., Omnaas, J. R. & Porreca, F. J. Pharmacol. Exp. Ther. 246, 950–955 (1988).
- Kitchen, I. et al. J. Pharmacol. Exp. Ther. 275, 1595–1607 (1995).
Cited by
Items 301–400 of 1,002
Substance abuse vulnerability loci: converging genome scanning data
Uhl, G. R., Liu, Q., & Naiman, D. Q. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02719-1 · Cited by 109
Increased rewarding properties of morphine in dopamine‐transporter knockout mice
Spielewoy, C., Gonon, F., Roubert, C., Fauchey, V., Jaber, M., Caron, M. G., Roques, B. P., Hamon, M., Betancur, C., Maldonado, R., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00063.x · Cited by 94
“This dose has been previously shown to induce an hyperlocomotor response (Matthes et al., 1996; Maldonado et al., H A L author m anuscript inserm -00126167, version 1 1997) and intense rewarding effects in the place-conditioned paradigm, which do not increase when using higher doses of morphine…”
BackgroundSelf-citationIrritable bowel syndrome patients show altered sensitivity to exogenous opioids
Lembo, T., Naliboff, B. D., Matin, K., Munakata, J., Parker, R. A., Gracely, R. H., & Mayer, E. A. (2000) · Pain · doi:10.1016/s0304-3959(00)00282-7 · Cited by 94
“Similarly, mu opioid receptor knock-out mice do not show an analgesic response to exogenously administered mu opioid agonists (Matthes et al., 1996).”
BackgroundBalogh, S. A., McDowell, C. S., Stavnezer, A. J., & Denenberg, V. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01586-3 · Cited by 104
Deciphering µ‐opioid receptor phosphorylation and dephosphorylation in HEK293 cells
Doll, C., Pöll, F., Peuker, K., Loktev, A., Glück, L., & Schulz, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02080.x · Cited by 96
“Morphine exerts all of its pharmacological effects by interacting with the m-opioid receptor (Matthes et al., 1996).”
BackgroundKon, R., Ikarashi, N., Hayakawa, A., Haga, Y., Fueki, A., Kusunoki, Y., Tajima, M., Ochiai, W., Machida, Y., & Sugiyama, K. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv055 · Cited by 92
Nieto, M. M., Guen, S. L., Kieffer, B. L., Roques, B. P., & Noble, F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.025 · Cited by 93
Self-citationMechanisms of Action of Drugs of Abuse on the Developing Fetal Brain
Malanga, C. J., & Kosofsky, B. E. (1999) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30070-8 · Cited by 97
Thompson, C. M., Wojno, H., Greiner, E., May, E. L., Rice, K. C., & Selley, D. E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058602 · Cited by 92
“This interpretation is in agreement with -receptor knockout studies indicating an absolute requirement for this receptor in analgesia and other in vivo effects of morphine (Matthes et al., 1996; Sora et al., 1997; Loh et al., 1998).”
BackgroundResultRougeot, C., Messaoudi, M., Hermitte, V., Rigault, A. G., Blisnick, T., Dugave, C., Desor, D., & Rougeon, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431850100 · Cited by 92
Morphine-Induced Receptor Endocytosis in a Novel Knockin Mouse Reduces Tolerance and Dependence
Kim, J. A., Bartlett, S. E., Li, H., Nielsen, C. K., Chang, A. M., Kharazia, V., Waldhoer, M., Ou, C. J., Taylor, S., Ferwerda, M., et al. (2008) · Current Biology · doi:10.1016/j.cub.2007.12.057 · Cited by 93
Anti–PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates
Wang, Z., Jiang, C., He, Q., Matsuda, M., Han, Q., Wang, K., Bang, S., Ding, H., Ko, M., & Ji, R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw6471 · Cited by 95
“MOR mediates both the beneficial effects (such as antinociception) and the unwanted side effects of morphine (such as hyperalgesia, tolerance, and withdrawal responses) (11, 14).”
BackgroundThe Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
Aquino, J. P. D., Parida, S., & Sofuoglu, M. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-021-01032-7 · Cited by 95
“While MOR and ORL-1 mediate the rewarding and analgesic effects of opioids [17], DOR participate in mood-regulation [18] and KOR mediate analgesic, dysphoric, and psychotomimetic effects [14, 19].”
BackgroundMu and Delta Opioid Receptors Oppositely Regulate Motor Impulsivity in the Signaled Nose Poke Task
Olmstead, M. C., Ouagazzal, A.-M., & Kieffer, B. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004410 · Cited by 90
“previously [12,18].”
Self-citationYao, L., McFarland, K., Fan, P., Jiang, Z., Inoue, Y., & Diamond, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503419102 · Cited by 90
Synaptic changes induced by melanocortin signalling
Caruso, V., Lagerström, M. C., Olszewski, P. K., Fredriksson, R., & Schiöth, H. B. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3657 · Cited by 88
Neural basis of opioid-induced respiratory depression and its rescue
Liu, S., Kim, D.-I., Oh, T. G., Pao, G. M., Kim, J.-H., Palmiter, R. D., Banghart, M. R., Lee, K.-F., Evans, R. M., & Han, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022134118 · Cited by 89
Law, P., Loh, H. H., & Wei, L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.013 · Cited by 89
Mu‐opioid receptor activation induces transcriptional plasticity in the central extended amygdala
Befort, K., Filliol, D., Ghate, A., Darcq, E., Matifas, A., Muller, J., Lardenois, A., Thibault, C., Dembele, D., Le Merrer, J., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06273.x · Cited by 89
“lacking mu-opioid receptor was previously described (Matthes et al., 1996).”
BackgroundMethodInfluentialSelf-citationAnalgesic synergy between opioid and α 2 ‐adrenoceptors
Chabot‐Doré, A., Schuster, D. J., Stone, L. S., & Wilcox, G. L. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12695 · Cited by 89
“MOP receptor for analgesic activity (Matthes et al., 1996; Sora et al., 1997), synergizes at the spinal level with several α2-adrenoceptor agonists including clonidine (Ossipov et al.”
BackgroundInfluentialMattioli, T. A., Leduc-Pessah, H., Skelhorne-Gross, G., Nicol, C. J. B., Milne, B., Trang, T., & Cahill, C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097361 · Cited by 89
“Their hallmark analgesia is predominantly mediated by activation of Gi/o protein-coupled mu opioid receptors [1,2], which are expressed throughout the central nervous system.”
BackgroundDelta Opioid Receptor Enhancement of Mu Opioid Receptor-Induced Antinociception in Spinal Cord
He, L., & Lee, N. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37501-9 · Cited by 89
Buckner, C. M., Luers, A. J., Calderon, T. M., Eugenin, E. A., & Berman, J. W. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9017-3 · Cited by 88
“Morphine The m-opioid class of receptors (MOR) is associated with the effects of heroin, and its major metabolite, morphine (Matthes et al. 1996).”
BackgroundConsolidating the Circuit Model for Addiction
Lüscher, C., & Janak, P. H. (2021) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-092920-123905 · Cited by 94
“The major inputs to the OFC are the medial dorsal thalamus and the sensory cortices (Chen et al. 2014,Mátyás et al. 2014,Ongür & Price 2000).”
BackgroundZhang, Z., Xu, F., Zhang, C., & Liang, X. (2007) · Anesthesiology · doi:10.1097/01.anes.0000270760.46821.67 · Cited by 88
“tion of -receptor agonists did not produce this depression in receptor–deficient mice.(12,15,18) Currently, it is”
BackgroundStain‐Texier, F., Boschi, G., Sandouk, P., & Scherrmann, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702873 · Cited by 88
“The a nity with which M6G binds to the m opioid receptors, which are important in mediating analgesia (Matthes et al., 1996), is 3 ± 4 times lower than that of morphine in vitro (Christensen & Jorgensen, 1987; Paul et al., 1989) and ®ve times lower in vivo (Frances et al., 1992).”
BackgroundBehavior in Mice with Targeted Disruption of Single Genes
Nelson, R. J., & Young, K. A. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00053-5 · Cited by 92
Olivar, T., & Laird, J. M. A. (1999) · European Journal of Pain · doi:10.1053/eujp.1998.0105 · Cited by 87
Laurent, V., Leung, B., Maidment, N., & Balleine, B. W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4688-11.2012 · Cited by 86
“Knock-out mice were bred at University of California, Los Angeles (UCLA); MOR (Matthes et al., 1996) and DOR (Filliol et al., 2000) KO mice and their WT littermates were generated from HET breeding pairs, backcrossed at least nine generations onto a C57BL/6 background.”
MethodHarburg, G. C., Hall, F. S., Harrist, A. V., Sora, I., Uhl, G. R., & Eisch, A. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.018 · Cited by 87
“…memory in MOR KO mice is warranted given differences in key physiological measures and behavior among distinct transgenic MOR KO mice (Matthes et al., 1996, Sora et al., 1997, Kitanaka et al., 1998, Loh et al., 1998, Schuller et al., 1999, Matthies et al., 2000, Jamot et al., 2003,…”
BackgroundKim, M., Cheong, Y. P., So, H., Lee, K., Kim, T.-Y., Oh, J.-M., Chung, Y.-T., Son, Y. H., Kim, B., & Park, R. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00541-x · Cited by 88
Fitting, S., Knapp, P. E., Zou, S., Marks, W. D., Bowers, M. S., Akbarali, H. I., & Hauser, K. F. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5351-13.2014 · Cited by 95
“The MOR knock-out mouse has been well characterized (Matthes et al., 1996; Martin et al., 2003; Chefer et al., 2009; Burbassi et al., 2010; Laurent et al., 2012).”
BackgroundNaloxone fails to produce conditioned place aversion in μ-opioid receptor knock-out mice
Skoubis, P. D., Matthes, H. W. D., Walwyn, W. M., Kieffer, B. L., & Maidment, N. T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00333-5 · Cited by 86
“…between MOR and DOR have been implicated by pharmacological data (e.g., Traynor and Elliott, 1993) and further suggested by the observation that DOR-mediated analgesia may be modi¢ed in MOR3/3 mice (Sora et al., 1997, 1999; Matthes et al., 1998; Qiu et al., 2000) (although see Loh et al., 1998).”
BackgroundSelf-citationNitrous Oxide Produces Antinociceptive Response via α2Band/or α2CAdrenoceptor Subtypes in Mice
Guo, T.-Z., Davies, F. M., Kingery, W. S., Patterson, A. J., Limbird, L. E., & Maze, M. (1999) · Anesthesiology · doi:10.1097/00000542-199902000-00022 · Cited by 86
Chen, H., Noble, F., Mothé, A., Meudal, H., Coric, P., Nascimento, S. D., Roques, B. P., George, P. G., & Fournié‐Zaluski, M. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990483l · Cited by 85
Self-citationRelevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers
Lötsch, J., & Geißlinger, G. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500362 · Cited by 85
Morphine and Heroin Differentially Modulate In Vivo Hippocampal LTP in Opiate-Dependent Rat
Bao, G., Kang, L., Li, H., Li, Y., Pu, L., Xia, P., Ma, L., & Pei, G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301308 · Cited by 94
“Therefore, it is worth further studying, whether differential changes of the mu-receptor variants really exist during the chronic morphine or heroin treatment and whether heroin metabolites, 6-MAM or further M6G, may share the different signaling pathways other than morphine owing to the different receptor populations.”
BackgroundInfluentialμ- and κ-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors
Kim, E., Clark, A. L., Kiss, A., Hahn, J. W., Wesselschmidt, R. L., Coscia, C. J., & Belcheva, M. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603862200 · Cited by 99
Generation of dynorphin knockout mice
Sharifi, N., Diehl, N. L., Yaswen, L. R., Brennan, M. B., & Hochgeschwender, U. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00264-3 · Cited by 84
A locus and mechanism of action for associative morphine tolerance
Mitchell, J., Basbaum, A. I., & Fields, H. L. (2000) · Nature Neuroscience · doi:10.1038/71120 · Cited by 87
Morphine enhances Tat-induced activation in murine microglia
Bokhari, S. M., Yao, H., Bethel-Brown, C., Fuwang, P., Williams, R., Dhillon, N. K., Hegde, R., Kumar, A., & Buch, S. J. (2009) · Journal of Neurovirology · doi:10.1080/13550280902913628 · Cited by 84
“Analysis of the opioid receptor expression showed a 14-fold up-regulation in the mRNA levels of the m-opioid receptor (Figure 1C), whereas those for k- and d-opioid receptors remained unchanged (data not shown), supporting previous studies that morphine mediates its analgesic effects specifically through modulation of…”
ResultAn Opiate Cocktail that Reduces Morphine Tolerance and Dependence
Li, H., & Whistler, J. L. (2005) · Current Biology · doi:10.1016/j.cub.2005.04.052 · Cited by 84
Novel approaches to targeting neuropeptide systems
Roques, B. P. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01571-6 · Cited by 92
Self-citationThe human µ opioid receptor gene: 5´ regulatory and intronic sequences
Wendel, B., & Hoehe, M. R. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050246 · Cited by 87
“key effects of morphine have been shown to be completely lacking in MOR-knockout mice [ 2 ].”
BackgroundOpioid receptor endocytosis and activation of MAP kinase pathway
Trapaidze, N., Gomes, I., Cvejic, S., Bansinath, M., & Devi, L. A. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00002-4 · Cited by 83
The effects of trauma on brain and body: A unifying role for the midbrain periaqueductal gray
Terpou, B. A., Harricharan, S., McKinnon, M. C., Frewen, P., Jetly, R., & Lanius, R. A. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24447 · Cited by 82
“…(L), sympathetic nervous system (SNS), parasympathetic nervous system (PNS), heart rate (HR), blood pressure (BP), hypothalamus (HT), medial prefrontal cortex (mPFC), insula (Ins), amygdala (AMG) attachment behavior (Matthes et al., 1996; Moles, Kieffer, & D'Amato, 2004; van der Kolk, 1988).”
BackgroundDrug dependence and the endogenous opioid system
Gerrits, M. A. F. M., Lesscher, H. B. M., & van Ree, J. M. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.003 · Cited by 82
“Moreover, morphine- and heroin-induced conditioned place preference (CPP) were respectively abolished (Matthes et al., 1996) or did not develop in these mice (Contarino et al.”
BackgroundLenard, N. R., Daniels, D. J., Portoghese, P. S., & Roerig, S. C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.040 · Cited by 90
Evidence for endogenous opioid release in the amygdala during positive emotion
Koepp, M. J., Hammers, A., Lawrence, A. D., Asselin, M., Grasby, P. M., & Bench, C. J. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.08.032 · Cited by 91
“…the opioid system has been linked to the rewarding (pleasurable) effects of a variety of behaviours: affiliative behaviours (Panksepp et al., 1980a; Matthes et al., 1996; Moles et al., 2004), pain relief (Quirarte et al., 1998; Fields, 2007; Leknes and Tracey, 2008), palatable food intake…”
Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice
Skoubis, P. D., Lam, H. A., Shoblock, J., Narayanan, S., & Maidment, N. T. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03956.x · Cited by 82
“Mu opioid receptors are crucial mediators of the rewarding effects of exogenous opiates such as morphine (Negus et al., 1993; Matthes et al., 1996; Piepponen et al., 1997).”
BackgroundNicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Opioid receptor heteromers in analgesia
Costantino, C. M., Gomes, I., Stockton, S. D., Lim, M. P., & Devi, L. A. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.5 · Cited by 95
The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models
Welsch, L., Bailly, J., Darcq, E., & Kieffer, B. L. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.027 · Cited by 89
“A vast literature demonstrates that opioid drugs, used for medicinal and/or recreational purposes, act by stimulating this G protein coupled receptor (reviewed in (33, 34)) that mediates both their therapeutic and adverse effects (35).”
BackgroundSelf-citationScherrer, G., Befort, K., Contet, C., Becker, J. A. J., Matifas, A., & Kieffer, B. L. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03339.x · Cited by 83
Self-citationMorphine disrupts long-range synchrony of gamma oscillations in hippocampal slices
Whittington, M. A., Traub, R. D., Faulkner, H. J., Jefferys, J. G. R., & Chettiar, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5807 · Cited by 82
Darlison, M. G., Greten, F. R., Harvey, R. J., Kreienkamp, H., Stühmer, T., Zwiers, H., Lederis, K. P., & Richter, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8214 · Cited by 81
Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome
Mechling, A. E., Arefin, T., Lee, H.-L., Bienert, T., Reisert, M., Ben Hamida, S., Darcq, E., Ehrlich, A., Gaveriaux-Ruff, C., Parent, M. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601640113 · Cited by 80
“Neuropsychopharmacology 39(9):2049–2060.”
BackgroundSelf-citationKibaly, C., Xu, C., Cahill, C. M., Evans, C. J., & Law, P. (2018) · Nature reviews. Neuroscience · doi:10.1038/s41583-018-0092-2 · Cited by 88
Basal Signaling Activity of μ Opioid Receptor in Mouse Brain: Role in Narcotic Dependence
Wang, D., Raehal, K. M., Lin, E. T., Lowery, J. J., Kieffer, B. L., Bilsky, E. J., & Sadée, W. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054049 · Cited by 80
“MOR knockout (MOR / ) and control mice (MOR / ) (Matthes et al., 1996) were sacrificed without any treatment.”
BackgroundMethodSelf-citationContet, C., Gavériaux‐Ruff, C., Matifas, A., Caradec, C., Champy, M., & Kieffer, B. L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300934 · Cited by 89
“Mice lacking mu, delta, or kappa opioid receptors (MOR / , DOR / , and KOR / ) were generated by homologous recombination and have been described earlier (Matthes et al, 1996; Simonin et al, 1998; Filliol et al, 2000).”
Self-citationExperimental Genetic Approaches to Addiction
Laakso, A., Mohn, A. R., Gainetdinov, R. R., & Caron, M. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00972-8 · Cited by 84
Goody, R. J., Oakley, S. M., Filliol, D., Kieffer, B. L., & Kitchen, I. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02452-6 · Cited by 84
Self-citationDifferences in Drug-Induced Place Conditioning Between BALB/c and C57Bl/6 Mice
Belzung, C., & Barreau, S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00212-9 · Cited by 90
Cholecystokinin/opioid interactions
Wiesenfeld‐Hallin, Z., Lucas, G. D. A., Alster, P., Xu, X., & Hökfelt, T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01978-2 · Cited by 86
Decreased motivation to eat in µ‐opioid receptor‐deficient mice
Papaleo, F., Kieffer, B. L., Tabarin, A., & Contarino, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05595.x · Cited by 79
“Moreover, the PR results showed that lack of functional MORs does not abolish operant behaviour driven by hedonic valence of food.”
MethodSelf-citationSynaptic Mechanism for Functional Synergism between δ- and μ-Opioid Receptors
Zhang, Z., & Pan, Z. Z. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5968-09.2010 · Cited by 86
“Previous studies have shown that the majority of opioid effects, including analgesia, tolerance, and addiction, are primarily mediated by MORs, with the functions of the other two opioid receptors remaining illusive (Matthes et al., 1996; Contet et al., 2004).”
BackgroundSun, J., Chen, S., Chen, H., & Pan, H. (2018) · The Journal of Physiology · doi:10.1113/jp277428 · Cited by 78
Differential involvement of the Mu and Kappa opioid receptors in spatial learning
Jamot, L., Matthes, H. W. D., Simonin, F., Kieffer, B. L., & Roder, J. C. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00013.x · Cited by 78
“…mice allowed us to test the hypothesis that the MOR and KOR might be involved in spatial learning (Martinez et al. 1988) and mf LTP (Kieffer 1999; Matthes et al. 1996), whereas high peripheral doses of ligand alone cause analgesia (Braida et al. 1994) or locomotion problems (Kuzmin et al. 2000)…”
BackgroundMethodInfluentialSelf-citationYabaluri, N., & Medzihradsky, F. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.896 · Cited by 78
“The m-opioid receptor is the molecular target for potent analgesics such as morphine and fentanyl, which are indispensable in the management of pain despite their abuse potential (2).”
BackgroundPharmacogenetics of opioid receptors and addiction
Mayer, P., & Höllt, V. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000182781.87932.0d · Cited by 77
Nadal, X., La Porta, C., Andreea Bura, S., & Maldonado, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.077 · Cited by 76
Self-citationLack of reward and locomotor stimulation induced by heroin in μ-opioid receptor-deficient mice
Contarino, A., Picetti, R., Matthes, H. W. D., Koob, G. F., Kieffer, B. L., & Gold, L. H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01812-5 · Cited by 76
Self-citationDissociation of analgesic and rewarding effects of endomorphin-1 in rats
Wilson, A. M., Soignier, R. D., Zadina, J. E., Kastin, A. J., Nores, W. L., Olson, R. D., & Olson, G. A. (2000) · Peptides · doi:10.1016/s0196-9781(00)00340-5 · Cited by 76
Salvadori, S., Guerrini, R., Balboni, G., Bianchi, C., Bryant, S. D., Cooper, P. S., & Lazarus, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990165m · Cited by 76
Regulation of opioid receptor expression
Wei, L. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00123-0 · Cited by 76
Ivy and Neurogliaform Interneurons Are a Major Target of μ-Opioid Receptor Modulation
Krook-Magnuson, E., Luu, L., Lee, S.-H., Varga, C., & Soltesz, I. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2269-11.2011 · Cited by 75
“To further confirm that the observed effect of DAMGO was mediated by ORs, we recorded from Ivy and NGF cells in slices taken from OR knock-out mice (Matthes et al., 1996).”
Ethanol Reversal of Tolerance to the Respiratory Depressant Effects of Morphine
Hill, R., Lyndon, A., Withey, S., Roberts, J., Kershaw, Y., MacLachlan, J., Lingford-Hughes, A., Kelly, E., Bailey, C., Hickman, M., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.201 · Cited by 75
Xie, W., He, Y., Yang, Y., Li, Y.-F., Kang, K., Xing, B.-M., & Wang, Y. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0415-09.2009 · Cited by 84
“Although morphine acts primarily via -opioid receptor (MOR) (Matthes et al., 1996), evidence indicates that -opioid receptor (DOR) is also critical for the development of morphine antinociceptive tolerance (Abdelhamid et”
BackgroundA Novel Behavioral Fish Model of Nociception for Testing Analgesics
Correia, A. D., Cunha, S. R., Scholze, M., & Stevens, D. (2011) · Pharmaceuticals · doi:10.3390/ph4040665 · Cited by 84
Blanchet, C., & Lüscher, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072075399 · Cited by 75
Cox, E. H., Kerbusch, T., van der Graaf, P. H., & Danhof, M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37304-5 · Cited by 75
Zamarripa, C. A., Edwards, S. R., Qureshi, H. N., Yi, J. N., Blough, B. E., & Freeman, K. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.002 · Cited by 79
“Opioid agonists mediate their physiological actions through the G protein-coupled receptor (GPCR) family of opioid receptors, specifically the mu-opioid receptor (Kieffer, 1999; Matthes et al., 1996; Mello and Negus 1996).”
BackgroundGutridge, A. M., Robins, M. T., Cassell, R. J., Uprety, R., Mores, K. L., Ko, M. J., Pasternak, G. W., Majumdar, S., & van Rijn, R. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14913 · Cited by 81
“CPP to morphine is dependent on μOP expression (Matthes et al., 1996) but is enhanced in the absence of β-arrestin 2 (Bohn et al., 2003), which would suggest that a G protein-biased μOP agonists would have rewarding properties.”
BackgroundMechanisms of opioid-induced respiratory depression
Baldo, B. A., & Rose, M. A. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03300-7 · Cited by 74
“As mentioned above ( “The mu opioid receptor and RD” section), experiments with Oprm1deficient mice demonstrated the abolition of RD to an analgesic dose of morphine that provoked decreased respiratory frequency and increased respiration time in wild-type mice (Matthes et al. 1996; Sora et al. 1997).”
BackgroundAdenosine A2A receptors are involved in physical dependence and place conditioning induced by THC
Soria, G., Castañé, A., Berrendero, F., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03682.x · Cited by 74
Self-citationMolecular Insights Into μ Opioid Pharmacology: From the Clinic to the Bench
Pasternak, G. W. (2009) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181c49d2e · Cited by 82
Mu opioid receptors in the medial habenula contribute to naloxone aversion
Boulos, L., Hamida, S. B., Bailly, J., Maitra, M., Ehrlich, A. T., Gavériaux‐Ruff, C., Darcq, E., & Kieffer, B. L. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0395-7 · Cited by 81
Self-citationActivation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents
Tiwari, V., He, S.-Q., Huang, Q., Liang, L., Yang, F., Chen, Z., Tiwari, V., Fujita, W., Devi, L. A., Dong, X., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001768 · Cited by 82
“The analgesic effect of morphine is mediated primarily by m-OR activation.(41) In the peripheral nervous system, mand d-ORs are present in dorsal root ganglion (DRG) neurons.”
BackgroundMatynia, A., Parikh, S., Chen, B., Kim, P., McNeill, D. S., Nusinowitz, S., Evans, C. J., & Gorin, M. B. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.09.012 · Cited by 74
“Samer Hattar, Johns Hopkins University, MD) and OPRM1 (mOR) disrupted mice (Matthes et al., 1996) were generated by heterozygous heterozygous mating.”
Manduca, A., Lassalle, O., Sepers, M., Campolongo, P., Cuomo, V., Marsicano, G., Kieffer, B., Vanderschuren, L. J. M. J., Trezza, V., & Manzoni, O. J. J. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00211 · Cited by 73
“Female and male MOR receptor null mice (MOR−/−) on a 50% C57Bl6/J and 50% 129SvPAS genetic background (Matthes et al., 1996; age 4–7 weeks) were used to test MOR dependent action of CP55940, with WT littermates as control group (MOR+/+).”
MethodSelf-citationORL-1 and Mu opioid receptor antisera label different fibers in areas involved in pain processing
Monteillet-Agius, G., Fein, J. A., Antón, B., & Evans, C. J. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980928)399:3<373::aid-cne6>3.0.co;2-y · Cited by 79
“E-mail: monteill@ucla.edu Received 24 April 1997; Revised 29 April 1998; Accepted 13 May 1998 r 1998 WILEY-LISS, INC. receptor-knockout mice have confirmed the essential role of MOR in the mediation of morphine-induced antinociception (Matthes et al., 1996; Sora et al., 1997).”
BackgroundBurns, J. A., Kroll, D. S., Feldman, D. E., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00626 · Cited by 79
“MOP receptors are required to establish morphine place preference and physical dependence (68).”
BackgroundHall, F. S., Goeb, M., Li, X.-F., Sora, I., & Uhl, G. R. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.10.024 · Cited by 85
Analysis of [3H] bremazocine binding in single and combinatorial opioid receptor knockout mice
Simonin, F., Slowe, S. J., Becker, J. A. J., Matthes, H. W. D., Filliol, D., Chluba, J., Kitchen, I., & Kieffer, B. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00822-6 · Cited by 84
Self-citationEnhanced δ-opioid receptor-mediated antinociception in μ-opioid receptor-deficient mice
Qiu, C., Sora, I., Ren, K., Uhl, G. R., & Dubner, R. A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00813-4 · Cited by 72
Ventura, C., Zinellu, E., Maninchedda, E., & Maioli, M. (2003) · Circulation Research · doi:10.1161/01.res.0000065169.23780.0e · Cited by 72
Cen, B., Xiong, Y., Ma, L., & Pei, G. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.758 · Cited by 75
List of transgenic and knockout mice: behavioral profiles
Bolivar, V. J., Cook, M. N., & Flaherty, L. A. (2000) · Mammalian Genome · doi:10.1007/s003350010051 · Cited by 76
“…et al. 1997; Ueda et al. 1997 H Inui et al. 1998 N H H Palmiter et al. 1998 Halonen et al. 1993 N N N N Simonin et al. 1998 N N Sora et al. 1997 N Matthes et al. 1996 Tian et al. 1997 A Li et al. 1999 H H H N N Konig et al. 1996 A Zheng et al. 1999 N N N N Huang et al. 1995 L* N N Abeliovich et…”
Optimization of a series of mu opioid receptor (MOR) agonists with high G protein signaling bias
Kennedy, N. M., Schmid, C. L., Ross, N. C., Lovell, K. M., Yue, Z., Chen, Y. T., Cameron, M. D., Bohn, L. M., & Bannister, T. D. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01136 · Cited by 71
Hall, F. S., Drgonova, J., Jain, S., & Uhl, G. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.006 · Cited by 71
“Conditioned place preference induced by morphine or heroin is eliminated in homozygous MOR KO mice (Matthes et al., 1996; Sora et al., 2001a; Contarino et al., 2002; Hall et al., 2003).”
Background
Metadata
- Authors
- Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., Tzavara, E., Hanoune, J., Roques, B. P., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Surrey (GB)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Inserm (FR)
- Venue
- Nature
- Published
- 1996-10
- Volume
- 383
- Issue
- 6603
- Pages
- 819-823
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051746492
- Cited by
- 1,722
- References
- 25
- Citations by year
- 2026: 36 · 2025: 40 · 2024: 45 · 2023: 52 · 2022: 53 · 2021: 56 · 2020: 59 · 2019: 56 · 2018: 53 · 2017: 43 · 2016: 59 · 2015: 53 · 2014: 60 · 2013: 65 · 2012: 58
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- mu-opioid receptor, morphine, analgesia, opioid reward, place preference, opioid withdrawal, physical dependence, knockout mice, delta opioid receptor, kappa opioid receptor, opioid system, pain management
- MeSH terms
- Analgesics, Animals, Behavior, Animal, Cell Line, Enkephalins, Mice, Inbred C57BL, Morphine, Morphine Dependence, Narcotics, Reward, Substance Withdrawal Syndrome, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.